See how often patients are within, above or below target range
See glucose variability vs. target range
See if there are hypoglycemia events and when they are happening
See how often glucose values fall within target glucose range
See average glucose readings during different time intervals
Estimated A1C level is based on available sensor glucose data from the last 90 days
Estimated A1C is not similar to blood A1C and these numbers often differ.
See how much glucose data have been captured
Log glucose events and view individual glucose reading information
Encourage patients to visit MyFreeStyle.ca for more information and
to download the FreeStyle LibreLink app¶ so they can start sharing
glucose data with you remotely.
Stay connected to your patients with LibreView**
LibreView** provides secure, online access to patients’ glucose reports, so you can make informed diabetes management decisions.‡‡
Most private health insurance companies cover the FreeStyle Libre system. Did you know that many of these private insurers cover the FreeStyle Libre system for non-insulin using patients as well?*** Encourage patients to speak to their plan administrator to find out how they may be covered.
Getting your patients started is as simple as 1-2-3!
T1D=type 1 diabetes; T2D=type 2 diabetes.
* Data based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal-use sensor-based glucose monitoring systems.
† The reader can capture data from the sensor when it is within 1-4 cm of the sensor.
‡ Sensor is water-resistant in up to 1 metre (3 feet) of water. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
§ A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the FreeStyle LibreLink app or when symptoms do not match the app readings.
¶ The FreeStyle LibreLink app and the FreeStyle Libre reader have similar but not identical features. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the FreeStyle LibreLink app or when symptoms do not match the app readings. The FreeStyle Libre sensor communicates with the FreeStyle Libre reader that started it or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre reader will also communicate with the FreeStyle LibreLink app. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the MyFreeStyle.ca website for more information about device compatibility before using the app. Use of FreeStyle LibreLink requires registration with LibreView.
** The LibreView website is only compatible with certain operating systems and browsers. Please check www.libreview.com for additional information.
†† The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp and the FreeStyle LibreLink app requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
‡‡ Treatment decisions should not be based on real-time sensor glucose readings alone but instead should consider all the information on the results screen.
§§ Use of FreeStyle LibreLink requires registration with LibreView. Automatic upload requires a wireless internet connection or mobile data connection.
¶¶ To get a complete glycemic picture over the last 3 months, the sensor must be replaced every 14 days and the sensor must be scanned at least once every 8 hours.
*** Individual private drug plans can vary. Please have your patients check with their plan administrator and/or insurance company.
††† For people managing diabetes with insulin.
‡‡‡ For residents of Quebec, the following two criteria must be met: intensive insulin therapy (insulin pump treatment or ≥3 insulin injections per day), and frequent hypoglycemic events during the last year.
§§§ For people over 18 years of age with T1D.
¶¶¶ Sensors are available for eligible patients who meet the labelling requirements of 18 years or older with diabetes mellitus. Limit: one per registrant.
1. Bolinder J, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016;388(10057):2254-63.
2. Haak T, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2017;8(1):55-73.
3. Ajjan R. Insights from real world use of flash continuous glucose monitoring. Symposium presented at: American Diabetes Association 78th Scientific Sessions; June 22-26, 2018; Orlando, FL.
4. Seibold A, et al. A meta-analysis of real world observational studies on the impact of flash glucose monitoring on glycemic control as measured by A1C. Poster presented at: American Diabetes Association 78th Scientific Sessions; June 22-26, 2018; Orlando, FL.
5. Data on file, Abbott Diabetes Care.
This site is intended for Healthcare Professionals only. Visit patient site.
The FreeStyle Libre flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in adults aged 18 years and older with diabetes mellitus. Always read and follow the label/insert.
The FreeStyle Libre 2 flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people aged 4 years and older with diabetes mellitus. Always read and follow the label/insert.
You are now being redirected to a third-party website not under the control of Abbott. Abbott is not responsible for the contents of such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site by Abbott.
Do you wish to leave this site?